SANTAMARIA, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 1.117
NA - Nord America 743
AS - Asia 259
OC - Oceania 5
SA - Sud America 5
AF - Africa 1
Totale 2.130
Nazione #
US - Stati Uniti d'America 740
IT - Italia 346
PL - Polonia 221
IE - Irlanda 209
SE - Svezia 180
CN - Cina 153
SG - Singapore 88
DE - Germania 30
FI - Finlandia 26
FR - Francia 24
GB - Regno Unito 24
UA - Ucraina 20
BE - Belgio 19
IN - India 12
NL - Olanda 7
AU - Australia 4
AT - Austria 3
CA - Canada 3
EC - Ecuador 3
BR - Brasile 2
CH - Svizzera 2
RO - Romania 2
RU - Federazione Russa 2
VN - Vietnam 2
AL - Albania 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 2.130
Città #
Warsaw 220
Dublin 209
Chandler 141
Nyköping 100
Messina 90
Singapore 68
Beijing 58
Ann Arbor 53
Jacksonville 53
Ashburn 42
Boardman 33
Cambridge 30
Dearborn 30
Princeton 29
Medford 26
Des Moines 22
Brussels 17
Catania 16
Jinan 16
Shenyang 13
Woodbridge 13
Wilmington 12
Tianjin 10
Rome 8
Seattle 8
London 7
Milan 7
Ningbo 7
Bremen 6
Pune 6
San Mateo 6
Washington 6
Bari 5
Hebei 5
Houston 5
Nanjing 5
Venice 5
Cagliari 4
Haikou 4
Munich 4
New York 4
Scandicci 4
Taizhou 4
Trecastagni 4
Viagrande 4
Bologna 3
Capoterra 3
Hangzhou 3
Hefei 3
Hyderabad 3
Lanzhou 3
Los Angeles 3
Mascalucia 3
Modling 3
Ottawa 3
Quito 3
Aci Sant'antonio 2
Acireale 2
Ascoli Piceno 2
Auburn Hills 2
Caltagirone 2
Dong Ket 2
Florence 2
Greifswald 2
Helsinki 2
Lancaster 2
Margherita di Savoia 2
Nanchang 2
Parma 2
Pomezia 2
Ravenna 2
Riva 2
Taiyuan 2
Verona 2
Vittoria 2
Waanrode 2
Zhengzhou 2
Akron 1
Anconetta 1
Argelato 1
Augusta 1
Bagheria 1
Baricella 1
Belgirate 1
Binasco 1
Brasov 1
Brescia 1
Brisbane 1
Brutten 1
Carini 1
Casalnuovo Di Napoli 1
Casette 1
Castrofilippo 1
Chennai 1
Chongqing 1
Corigliano Calabro 1
Crotone 1
Curitiba 1
Dolo 1
Dumfries 1
Totale 1.517
Nome #
Myo-Inositolo: protocollo non farmacologico per la prevenzione del Diabete Gestazionale - Outcomes clinici e metabolici 273
Inositolo e sindrome metabolica in menopausa 196
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 115
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 110
Italian risk factor-based screening for gestational diabetes. 104
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 88
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 84
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 81
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 80
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 80
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 80
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 78
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 74
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 74
Myo-inositol and melatonin in the menopausal transition 69
Cadmium delays puberty onset and testis growth in adolescents 68
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 63
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 63
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 56
Maternal serum PAPP-A as an early marker of obstetric complications? 53
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 51
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 50
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 50
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension 48
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 45
Neutrophil Gelatinase-Associated Lipocalin (NGAL) e’ un marker di danno endoteliale? 36
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 30
Neutrophil Gelatinase-Associated Lipocalin (NGAL) e preeclampsia. 25
null 24
Totale 2.248
Categoria #
all - tutte 7.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020249 0 0 0 0 0 50 27 26 16 59 50 21
2020/2021334 20 14 65 13 29 16 33 37 44 44 12 7
2021/2022250 5 34 5 11 6 1 12 9 11 67 28 61
2022/2023597 43 78 27 32 46 52 7 24 261 1 23 3
2023/2024162 16 16 6 22 12 24 0 20 0 8 4 34
2024/2025148 10 10 19 42 34 33 0 0 0 0 0 0
Totale 2.248